References
- FerrandinaGLudovisiMLorussoDPhase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancerJ Clin Oncol200826689089618281662
- AlbaERuiz-BorregoMMargeliMMaintenance treatment with pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 studyBreast Cancer Res Treat2010122116917620361253
- GoebelFDGoldsteinDGoosMJablonowskiHStewartJSEfficacy and safety of stealth liposomal doxorubicin in AIDS-related Kaposi’s sarcoma. The International SL-DOX Study GroupBr J Cancer19967389899948611437
- Pujade-LauraineEWagnerUAavall-LundqvistEPegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapseJ Clin Oncol201028203323332920498395
- HongRLHuangCJTsengYLDirect comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?Clin Cancer Res19995113645365210589782
- CoukellAJSpencerCMPolyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi’s sarcomaDrugs19975335205389074848
- O’BrienMEWiglerNInbarMReduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancerAnn Oncol200415344044914998846
- ChaoTCWangWSYenCCA dose-escalating pilot study of sterically stabilized, pegylated liposomal doxorubicin (Lipo-Dox) in patients with metastatic breast cancerCancer Invest200321683784714735687
- KaczmarekABrinkmanBMHeyndrickxLVandenabeelePKryskoDVSeverity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathwaysJ Pathol2012226459860821960132
- KhemapechNOranratanaphanSTermrungruanglertWLertkhachonsukRVasurattanaASalvage chemotherapy in recurrent platinum-resistant or refractory epithelial ovarian cancer with carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox(R))Asian Pac J Cancer Prev20131432131213523679331
- LacoutureMEReillyLMGeramiPGuitartJHand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinibAnn Oncol200819111955196118550575
- BaackBRBurgdorfWHChemotherapy-induced acral erythemaJ Am Acad Dermatol19912434574612061446
- BakerTRPetersonREHeidemanWUsing zebrafish as a model system for studying the transgenerational effects of dioxinToxicol Sci2014138240341124470537
- LeleZKronePHThe zebrafish as a model system in developmental, toxicological and transgenic researchBiotechnol Adv1996141577214536924
- DingYJChenYHDevelopmental nephrotoxicity of aristolochic acid in a zebrafish modelToxicol Appl Pharmacol20122611596522472514
- WangYHChenYHLinYJTsaiHJSpatiotemporal expression of zebrafish keratin 18 during early embryogenesis and the establishment of a keratin 18:RFP transgenic lineGene Expr Patterns20066433533916446122
- WangYHChenYHWuTNLinYJTsaiHJA keratin 18 transgenic zebrafish Tg(k18(2.9):RFP) treated with inorganic arsenite reveals visible overproliferation of epithelial cellsToxicol Lett2006163319119716376500
- PaiCWChenYHTransgenic expression of prothymosin alpha on zebrafish epidermal cells promotes proliferation and attenuates UVB-induced apoptosisTransgenic Res201019465566520012190
- StuartGWVielkindJRMcMurrayJVWesterfieldMStable lines of transgenic zebrafish exhibit reproducible patterns of transgene expressionDevelopment199010935775842401211
- ShultsJMazurickCARichard LandisJAnalysis of repeated bouts of measurements in the framework of generalized estimating equationsStat Med200625234114412816479561
- SommersSCKorelitzBIMucosal-cell counts in ulcerative and granulomatous colitisAm J Clin Pathol1975633359365234674
- NorrisAALewisAJZeitlinIJChanges in colonic tissue levels of inflammatory mediators in a guinea-pig model of immune colitisAgents Actions1982121–22432466952749